Belite Bio (BLTE) Other Non-Current Assets (2021 - 2025)
Belite Bio's quarterly Other Non-Current Assets came in at $286.3 million in Q4 2025, up 277845.63% year-on-year from N/an in Q4 2024, and up 277845.63% quarter-over-quarter from $103000.0 in Q4 2024.
Belite Bio has reported Other Non-Current Assets for 5 years, with the latest figure at $286.3 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 277845.63% year-over-year to $286.3 million; the trailing twelve-month figure through Dec 2025 stood at $286.3 million (up 277845.63% YoY), and the FY2025 full-year result was $286.3 million, up 277845.63% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $286.3 million, up from $103000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $286.3 million in Q4 2025, with the low at $8000.0 in Q4 2021.
- Average Other Non-Current Assets over 5 years is $57.9 million, with a median of $103000.0 recorded in 2024.
- Year-over-year, Other Non-Current Assets sank 96.82% in 2024 and surged 277845.63% in 2025.
- Tracing BLTE's Other Non-Current Assets over 5 years: stood at $8000.0 in 2021, then soared by 1000.0% to $88000.0 in 2022, then surged by 3576.14% to $3.2 million in 2023, then slumped by 96.82% to $103000.0 in 2024, then surged by 277845.63% to $286.3 million in 2025.
- The last three Other Non-Current Assets figures came in at $286.3 million (Q4 2025), $103000.0 (Q4 2024), and $3.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | 286.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 253,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 4.91 Mn |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 4.55 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.68 Mn |
| Dec 31, 2023 | 104,000.00 |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 88,000.00 |
| Dec 31, 2021 | 917,000.00 |